[Obliterative arthropathies. Clinical findings and current status; the combination of acetylcholine, 2-pyridinemethanol and pyridostigmine in their therapy].
D000109:Acetylcholine / Q000628:therapy*; D006801:Humans; D007592:Joint Diseases; D010277:Parasympathomimetics / Q000628:therapy*; D011725:Pyridines / Q000628:therapy*; D011729:Pyridostigmine Bromide; D013919:Thromboangiitis Obliterans
D010277:Parasympathomimetics; D011725:Pyridines; D011729:Pyridostigmine Bromide; D000109:Acetylcholine
ACETYLCHOLINE/therapy; PARASYMPATHOMIMETICS/therapy; PYRIDINES/therapy; THROMBOANGIITIS OBLITERANS